- Home
- YI vs VANI Comparison
YI vs VANI Comparison
Compare YI & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YI
- VANI
- Stock Information
- Founded
- YI 2010
- VANI 1998
- Country
- YI China
- VANI United States
- Employees
- YI N/A
- VANI N/A
- Industry
- YI Retail-Drug Stores and Proprietary Stores
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- YI Consumer Staples
- VANI Health Care
- Exchange
- YI Nasdaq
- VANI Nasdaq
- Market Cap
- YI 70.0M
- VANI 68.1M
- IPO Year
- YI N/A
- VANI 2014
- Fundamental
- Price
- YI $8.17
- VANI $1.26
- Analyst Decision
- YI
- VANI Strong Buy
- Analyst Count
- YI 0
- VANI 1
- Target Price
- YI N/A
- VANI $4.00
- AVG Volume (30 Days)
- YI 12.9K
- VANI 66.4K
- Earning Date
- YI 06-10-2025
- VANI 05-13-2025
- Dividend Yield
- YI N/A
- VANI N/A
- EPS Growth
- YI N/A
- VANI N/A
- EPS
- YI N/A
- VANI N/A
- Revenue
- YI $1,973,017,082.00
- VANI N/A
- Revenue This Year
- YI N/A
- VANI N/A
- Revenue Next Year
- YI N/A
- VANI N/A
- P/E Ratio
- YI N/A
- VANI N/A
- Revenue Growth
- YI N/A
- VANI N/A
- 52 Week Low
- YI $4.15
- VANI $0.91
- 52 Week High
- YI $13.00
- VANI $2.09
- Technical
- Relative Strength Index (RSI)
- YI 54.03
- VANI 77.37
- Support Level
- YI $7.54
- VANI $1.13
- Resistance Level
- YI $8.16
- VANI $1.16
- Average True Range (ATR)
- YI 0.42
- VANI 0.05
- MACD
- YI 0.04
- VANI 0.02
- Stochastic Oscillator
- YI 79.25
- VANI 92.86
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.